BioNanomatrix, Inc.

BioNanomatrix, Inc. (BioNanomatrix) is a privately held company that is engaged in developing nanoscale imaging and analytic platforms which are used to analyze DNA and other genome-related peptides and proteins. The technology provides analysis of genomics, epigenomics, and proteomic information with sensitivity at the single molecule level. The products developed by Bionanomatrix are used in genetic diagnostics, personalized medicine, and biomedical research applications. The company is headquartered at Philadelphia in Pennsylvania, the US.

Recently, BioNanomatrix has issued US patent 7,670,770 for nanochannel arrays that enable high-throughput macromolecular analysis to Princeton University.

Street: 
3701 Market Street
City: 
Philadelphia
Postcode: 
19104
Federal State : 
United States
WebSite: 
www.bionanomatrix.com
Fax: 
1-267-4992015

Company Index Score

Current Index Score Historical Index Score
  • BioNanomatrix, Inc. currently scores 50 % in the index.
  • BioNanomatrix, Inc. is currently ranked equal 15 out of a total of 35419 included in the NS Company Index. This is the top 0.042 % of all companies.
  • BioNanomatrix, Inc. is currently ranked 3 out of 8430 companies. This is in the top 0.036 % percent of Healthcare companies ranked in the index.
  • User perception of the company stands at 0 % percent. This differs 50 % percent over the score attributed to the company by other scoring factors.

Latest tweets